PrimeRFP SCOUT · Federal Contract Recompete Brief

FA301626F0056Benzodiazepine reagent KITS — Microgenics Corp

Microgenics Corp holds $4.3M across 166 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 2 related awards under parent N6264523D5009. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

Fa3016 502 Cons Cl

Awarding office

Microgenics Corp

Recipient

Sep 30, 2026

PoP end

$176K

Obligated

$176K

Potential

334516

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Microgenics Corp — $90

Contract facts

Federal

Contract numberFA301626F0056

Also listed asFA3016-26-F-0056

Also listed asN6264523D5009-FA301626F0056

AgencyFa3016 502 Cons Cl

Awarding officeFa3016 502 Cons Cl

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentMicrogenics Corp

CAGE1MRF6

UEIE7WGWEK19Y79

NAICS334516

No full NAICS 334516 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDVN6264523D5009

Place of performanceLACKLAND AFB TX

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startDec 16, 2025

PoP end (current)Sep 30, 2026

PoP end (w/ options)Dec 31, 2026

Obligated$176K

Current value$176K

Potential value$176K

BENZODIAZEPINE REAGENT KITS is a federal award for Fa3016 502 Cons Cl held by Microgenics Corp. Estimated value $176K ($176K obligated). Current period of performance ends Sep 30, 2026 (potential Dec 31, 2026). Place of performance: LACKLAND AFB TX.

Recompete timing

Public

● Expiring in 40 days

Current PoP ends Sep 30, 2026 (40 days remaining). Agencies typically plan 12–18 months ahead — at 1.3 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Microgenics Corp — $4.3M obligated across 166 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($4.3M) · all agencies

Department of Defense (DOD)$3.9M · 91%Department of Veterans Affairs (VA)$411K · 10%

Open full company profile →

Related awards

Same parent · incumbent

36C26326N0005

TOXICOLOGY REAGENTS - MODIFICATION TO ADD A LINE ITEM TO THE BASE YEAR AND EACH OPTION YEA…

$165K

Sep 30, 2026

W81K0226FA033

BENZODIAZEPINE REAGENT KITS FOR TRIPLER ARMY MEDICAL CENTER (TAMC), HAWAII.

$164K

Oct 15, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract FA301626F0056?

FA301626F0056 (Benzodiazepine reagent KITS) is a Fa3016 502 Cons Cl award with a potential value of $176K, currently held by Microgenics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is FA3016-26-F-0056?

FA3016-26-F-0056 is the dashed form of PIID FA301626F0056 (Benzodiazepine reagent KITS), held by Microgenics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded FA301626F0056?

Fa3016 502 Cons Cl awarded FA301626F0056 to Microgenics Corp (potential $176K).

Who is the incumbent on FA301626F0056?

Microgenics Corp is the incumbent with $4.3M across 166 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Microgenics Corp’s FA301626F0056 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Dec 16, 2025